# Vascular Inflammation ReDuction and Perivascular Fat Imaging by Computed Tomography

Study · id `cardio:ct-nct06083337` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06083337](<https://clinicaltrials.gov/study/NCT06083337>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06083337

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 140 participants.

## Technical summary

Registry record NCT06083337. Randomized; no masking; primary purpose prevention. Start 2022-01-22 (actual); primary completion 2025-07-22 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Not applicable
- Enrolled: 140 participants (planned count; ClinicalTrials.gov record NCT06083337, source copy `cardio:ctgov-nct06083337-2023-10-16`, retrieved 2026-10-26)
- Started: 2022-01-22 (actual) (ClinicalTrials.gov record NCT06083337, source copy `cardio:ctgov-nct06083337-2023-10-16`, retrieved 2026-10-26)
- Primary completion: 2025-07-22 (anticipated) (ClinicalTrials.gov record NCT06083337, source copy `cardio:ctgov-nct06083337-2023-10-16`, retrieved 2026-10-26)
- Completion: 2025-07-22 (anticipated) (ClinicalTrials.gov record NCT06083337, source copy `cardio:ctgov-nct06083337-2023-10-16`, retrieved 2026-10-26)
- Countries: Greece (ClinicalTrials.gov record NCT06083337, source copy `cardio:ctgov-nct06083337-2023-10-16`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06083337-2023-10-16`, retrieved 2026-10-26)

## The registry's words

- Brief title: Vascular Inflammation ReDuction and Perivascular Fat Imaging by Computed Tomography
- Acronym: VIRDICT
- Condition: Coronary Artery Disease
- Condition: Atheroscleroses, Coronary
- Condition: Vascular Inflammation
- Intervention (Device): CaRi-Heart device
- Lead sponsor: Hippocration General Hospital
- Lead sponsor class: OTHER
- Collaborator: Biomedical Research Foundation, Academy of Athens
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Hippocration General Hospital (`cardio:org-hippocration-general-hospital`)

## Provenance

Content hash: 2f5694b272a6d060045c2e871fde5ce1c78ad528c5e0d3b595969a65eb2f74e9
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
